Related Experiment Video

Updated: Jan 9, 2026

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer
08:29

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer

Published on: November 1, 2019

7.6K

Sumoylation of cyclin and its therapeutic potential for cancer

Hong-Yeoul Ryu1, Mark Hochstrasser2

  • 1KNU G-LAMP Project Group, KNU Institute of Basic Sciences, School of Life Sciences, BK21 FOUR KNU Creative BioResearch Group, College of Natural Sciences, Kyungpook National University, Daegu, 41566, South Korea.

Animal Cells and Systems
|December 10, 2025
PubMed

Insights

Sumoylation precisely regulates cyclins D and E, crucial for cell cycle control and preventing cancer. Targeting this modification offers new precision medicine strategies for cyclin-related malignancies.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Biochemistry

Background:

  • Cell cycle progression relies on precise regulation by cyclins and cyclin-dependent kinases (CDKs).
  • Post-translational modifications, especially sumoylation, are increasingly recognized as critical regulators of cyclin function.
  • Dysregulation of the cell cycle is a fundamental aspect of cancer development.

Purpose of the Study:

  • To review the role of sumoylation in governing cyclin dynamics and cell cycle fidelity.
  • To explore the implications of aberrant sumoylation in cancer progression.
  • To discuss the therapeutic potential of targeting the SUMO pathway for malignancies.

Main Methods:

  • Literature review of recent studies on sumoylation, cyclins, and cell cycle regulation.
  • Analysis of the impact of sumoylation on cyclin stability, localization, and activity.
  • Examination of the link between sumoylation, cyclin dysregulation, and oncogenesis.

Main Results:

  • Sumoylation critically influences the stability, localization, and activity of cyclins D and E, essential for the G1/S transition.
  • Aberrant sumoylation of cyclins can enhance their oncogenic potential, contributing to cancer progression.
  • The SUMO pathway represents a promising target for therapeutic intervention in cyclin-related cancers.

Conclusions:

  • Sumoylation is a key regulator of cyclin function, maintaining cell division fidelity.
  • Targeting sumoylation pathways offers novel therapeutic strategies for precision medicine in oncology.
  • Further understanding of sumoylation's role in cyclin regulation may revolutionize treatments for cyclin-dependent diseases.
Keywords:
CDKCyclin Dcancercyclin Esumoylation

More Related Videos

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells09:40

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells

Published on: November 2, 2017

7.7K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.0K

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.4K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
133.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K